Related Experiment Video
Updated: Apr 21, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.7K
Topical steroid addiction in atopic dermatitis
Mototsugu Fukaya1, Kenji Sato2, Mitsuko Sato3
1Tsurumai Kouen Clinic, Nagoya, Japan.
Drug, Healthcare and Patient Safety
|November 8, 2014
Summary
Topical steroid addiction, or red burning skin syndrome, remains controversial. This article details its clinical features to improve understanding and encourage further discussion on this adverse effect of topical steroids.
Area of Science:
- Dermatology
- Adverse Drug Reactions
Background:
- The American Academy of Dermatology's 2014 guidelines on atopic dermatitis topical therapy do not address topical steroid addiction (TSA) or red burning skin syndrome (RBSS).
- A 2006 review mentioned TSA/RBSS as potential side effects of topical steroids, indicating ongoing debate.
- The lack of inclusion in recent guidelines suggests controversy surrounding TSA/RBSS.
Purpose of the Study:
- To describe the clinical features of topical steroid addiction or red burning skin syndrome.
- To contribute to a better understanding of this condition.
- To stimulate further discussion and research regarding TSA/RBSS.
Main Methods:
- Clinical features were described based on the treatment of numerous cases.
- Literature review of existing articles on topical steroid addiction/red burning skin syndrome.
Main Results:
- The article provides a detailed description of the clinical presentation of TSA/RBSS.
- Highlights the limited existing medical literature on the subject.
Conclusions:
- Topical steroid addiction or red burning skin syndrome is a condition with debated recognition.
- Further clinical descriptions and research are needed to fully understand and address TSA/RBSS.
- This article aims to provide a foundation for future discussions and management strategies.
Keywords:
atopic dermatitiscorticosteroideczemareboundred burning skin syndrometopical steroid addictionMore Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.8K
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.8K
Related Concept Videos
01:17Drug Dependence
2.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
2.0K
01:30Drug Toxicity: Allergic Reactions
184
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
184
01:22Drug Delivery: Miscellaneous Routes
1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
01:20Desensitization and Tachyphylaxis
3.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
01:18Transdermal Drug Delivery Systems
203
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
203